Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells
Daeun You(Samsung Medical Center), Sangmin Kim(Samsung Medical Center)
Cited by 27
Related Papers
Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway
|Oncotarget|2015|46
Celastrol attenuates the inflammatory response by inhibiting IL‑1β expression in triple‑negative breast cancer cells
|Oncology Reports|2021|38
Induction of fibronectin in response to epidermal growth factor is suppressed by silibinin through the inhibition of STAT3 in triple negative breast cancer cells
|Oncology Reports|2014|30
Tumorigenicity of EGFR- and/or HER2-Positive Breast Cancers Is Mediated by Recruitment of Tumor-Associated Macrophages
|International Journal of Molecular Sciences|2023|10
Wild-type p53 controls the level of fibronectin expression in breast cancer cells
|Oncology Reports|2017|9